Quantitative and Qualitative Alterations of Heparan Sulfate in Fibrogenic Liver Diseases and Hepatocellular Cancer
Open Access
- 1 February 2010
- journal article
- research article
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 58 (5), 429-441
- https://doi.org/10.1369/jhc.2010.955161
Abstract
Heparan sulfate (HS), duetoits abilitytointeract with a multitude of HS-binding factors, is involved in a variety of physiological and pathological processes. Remarkably diverse fine structure of HS, shaped by non-exhaustive enzymatic modifications, influences the interaction of HS with its partners. Here we characterized the HS profile of normal human and rat liver, as well as alterations of HS related to liver fibrogenesis and carcinogenesis, by using sulfation-specific antibodies. The HS immunopattern was compared with the immunolocalization of selected HS proteoglycans. HS samples from normal liver and hepatocellular carcinoma (HCC) were subjected to disaccharide analysis. Expression changes of nine HS-modifying enzymes in human fibrogenic diseases and HCC were measured by quantitative RT-PCR. Increased abundance and altered immunolocalization of HS was paralleled by elevated mRNA levels of HS-modifying enzymes in the diseased liver. The strong immunoreactivity of the normal liver for 3- O-sulfated epitope further increased with disease, along with upregulation of 3-OST-1. Modest 6- O-undersulfation of HCC HS is probably explained by Sulf overexpression. Our results may prompt further investigation of the role of highly 3- O-sulfated and partially 6- O-desulfated HS in pathological processes such as hepatitis virus entry and aberrant growth factor signaling in fibrogenic liver diseases and HCC.Keywords
This publication has 48 references indexed in Scilit:
- Heparin-Degrading Sulfatases in Hepatocellular Carcinoma: Roles in Pathogenesis and Therapy TargetsFuture Oncology, 2008
- Heparan sulphate proteoglycans in glia and in the normal and injured CNS: expression of sulphotransferases and changes in sulphationEuropean Journal of Neuroscience, 2008
- Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinomaHepatology, 2008
- Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycansHepatology, 2007
- Characterization of anticoagulant heparinoids by immunoprofilingGlycoconjugate Journal, 2007
- Pancreatic cancer–associated stroma productionThe American Journal of Surgery, 2007
- Heparan sulphate proteoglycans fine-tune mammalian physiologyNature, 2007
- Heparan Sulfate Analysis from Diabetic Rat GlomeruliPublished by Elsevier BV ,2007
- Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteractionJournal of Virology, 2006
- Enzymatic Modification of Heparan Sulfate on a Biochip Promotes Its Interaction with Antithrombin IIIBiochemical and Biophysical Research Communications, 2000